OCUGEN, INC. Preferred Stock Dividends and Other Adjustments
OCUGEN, INC. (OCGN) reported Preferred Stock Dividends and Other Adjustments of $0 for the 3-month period ending 2024-06-30, per its 10-Q filed 2025-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2025-08-04
- OCUGEN, INC. preferred stock dividends and other adjustments for the quarter ending 2024-06-30 was $0.00.
- OCUGEN, INC. preferred stock dividends and other adjustments for the quarter ending 2023-06-30 was $0.00.
- OCUGEN, INC. preferred stock dividends and other adjustments for the quarter ending 2021-12-31 was $0.00.
- OCUGEN, INC. preferred stock dividends and other adjustments for the quarter ending 2021-09-30 was $0.00.
- OCUGEN, INC. preferred stock dividends and other adjustments for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- OCUGEN, INC. preferred stock dividends and other adjustments for fiscal 2020 was $12.55M.
- OCUGEN, INC. preferred stock dividends and other adjustments for fiscal 2019 was $0.00.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 3 month as first filed | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 6 month as first filed | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 9 month as first filed | Preferred Stock Dividends and Other Adjustments 12 month | Preferred Stock Dividends and Other Adjustments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | -$4.99M 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2025-08-04 | -$4.99M 10-Q · filed 2024-08-08 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $12.55M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $12.55M derived: sum of 3 quarters · filed 2022-02-28 | $12.55M 10-K · filed 2022-02-28 | $12.55M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $12.55M derived: sum of 2 quarters · filed 2021-11-09 | $12.55M 10-Q · filed 2021-11-09 | $12.55M 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $12.55M 10-Q · filed 2021-08-06 | $12.55M 10-Q · filed 2020-08-14 | $12.55M 10-Q · filed 2021-08-06 | $12.55M 10-Q · filed 2020-08-14 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |